Endocrine Pathology

Springer Science+Business Media

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Endocrine Pathology is a journal published by Springer Science+Business Media in United States. It is listed in MEDLINE according to the sources read. Declared publication charge: 4,390 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Science+Business Media
ISSN
1046-3976 · 1559-0097
Country
United States
Access
Not open access / not declared
Declared publication charge
4,390 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2001-01-01
Indexing
MEDLINE
APC
4,390 EUR
Declared review time (DOAJ)
—
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

1706

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

76

i10-index

958

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-09-21
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
93%
ORCID iDs in current deposits
53%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9009288
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Thyroid Cancer Diagnosis and Treatment
  • Thyroid Cancer Diagnosis and Treatment
  • Neuroendocrine Tumor Research Advances
  • Neuroendocrine Tumor Research Advances
  • Pituitary Gland Disorders and Treatments
  • Pituitary Gland Disorders and Treatments
  • Adrenal and Paraganglionic Tumors
  • Adrenal and Paraganglionic Tumors
Show all subjects (50)
  • Neuroblastoma Research and Treatments
  • Neuroblastoma Research and Treatments
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Lung Cancer Research Studies
  • Lung Cancer Research Studies
  • Growth Hormone and Insulin-like Growth Factors
  • Growth Hormone and Insulin-like Growth Factors
  • Head and Neck Anomalies
  • Head and Neck Anomalies
  • Glioma Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Genetic factors in colorectal cancer
  • Genetic factors in colorectal cancer
  • Cancer-related Molecular Pathways
  • Cancer-related Molecular Pathways
  • Hormonal Regulation and Hypertension
  • Hormonal Regulation and Hypertension
  • Pancreatic and Hepatic Oncology Research
  • Pancreatic and Hepatic Oncology Research
  • Ovarian cancer diagnosis and treatment
  • Ovarian cancer diagnosis and treatment
  • BRCA gene mutations in cancer
  • BRCA gene mutations in cancer
  • Parathyroid Disorders and Treatments
  • Parathyroid Disorders and Treatments
  • Thyroid Disorders and Treatments
  • Salivary Gland Tumors Diagnosis and Treatment
  • Salivary Gland Tumors Diagnosis and Treatment
  • Thyroid Disorders and Treatments
  • Thyroid and Parathyroid Surgery
  • Thyroid and Parathyroid Surgery
  • Pancreatic function and diabetes
  • Genetic Syndromes and Imprinting
  • Pancreatic function and diabetes
  • Genetic Syndromes and Imprinting
  • Adrenal Hormones and Disorders
  • Adrenal Hormones and Disorders
  • Cancer Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
  • Neurofibromatosis and Schwannoma Cases
  • Neurofibromatosis and Schwannoma Cases

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: